Completed
Safety and Tolerability of LEO 138559 in Healthy Subjects and Subjects With Atopic Dermatitis
NCT03514511
- Conditions
- Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +9 more
- Locations
-
- Investigational site Leeds, United Kingdom
- Investigational site Liverpool, United Kingdom
- LEO Pharma investigational site Manchester, United Kingdom